These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36684707)

  • 1. Stable High-Concentration Monoclonal Antibody Formulations Enabled by an Amphiphilic Copolymer Excipient.
    Klich JH; Kasse CM; Mann JL; Huang Y; d'Aquino AI; Grosskopf AK; Baillet J; Fuller GG; Appel EA
    Adv Ther (Weinh); 2023 Jan; 6(1):. PubMed ID: 36684707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation Excipients and Their Role in Insulin Stability and Association State in Formulation.
    Maikawa CL; Nguyen LT; Mann JL; Appel EA
    Pharm Res; 2022 Nov; 39(11):2721-2728. PubMed ID: 35978148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Formulation Development Approach to Identify and Select Stable Ultra-High-Concentration Monoclonal Antibody Formulations With Reduced Viscosities.
    Whitaker N; Xiong J; Pace SE; Kumar V; Middaugh CR; Joshi SB; Volkin DB
    J Pharm Sci; 2017 Nov; 106(11):3230-3241. PubMed ID: 28668340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near Infrared Spectroscopy as a PAT tool for monitoring and control of protein and excipient concentration in ultrafiltration of highly concentrated antibody formulations.
    Thakur G; Hebbi V; Rathore AS
    Int J Pharm; 2021 May; 600():120456. PubMed ID: 33711473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable Monomeric Insulin Formulations Enabled by Supramolecular PEGylation of Insulin Analogues.
    Maikawa CL; Smith AAA; Zou L; Meis CM; Mann JL; Webber MJ; Appel EA
    Adv Ther (Weinh); 2020 Jan; 3(1):. PubMed ID: 32190729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranking mAb-excipient interactions in biologics formulations by NMR spectroscopy and computational approaches.
    Zhang C; Gossert ST; Williams J; Little M; Barros M; Dear B; Falk B; Kanthe AD; Garmise R; Mueller L; Ilott A; Abraham A
    MAbs; 2023; 15(1):2212416. PubMed ID: 37218059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxylpropyl-β-cyclodextrin as Potential Excipient to Prevent Stress-Induced Aggregation in Liquid Protein Formulations.
    Stolzke T; Krieg F; Peng T; Zhang H; Häusler O; Brandenbusch C
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Protein-Excipient Microheterogeneity in Biopharmaceutical Solid-State Formulations by Confocal Fluorescence Microscopy.
    Koshari SH; Ross JL; Nayak PK; Zarraga IE; Rajagopal K; Wagner NJ; Lenhoff AM
    Mol Pharm; 2017 Feb; 14(2):546-553. PubMed ID: 28094996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine as a Viscosity Reducer for Highly Concentrated Monoclonal Antibody Solutions.
    Zeng Y; Tran T; Wuthrich P; Naik S; Davagnino J; Greene DG; Mahoney RP; Soane DS
    J Pharm Sci; 2021 Nov; 110(11):3594-3604. PubMed ID: 34181992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histidine as a versatile excipient in the protein-based biopharmaceutical formulations.
    Lv JY; Ingle RG; Wu H; Liu C; Fang WJ
    Int J Pharm; 2024 Jul; 662():124472. PubMed ID: 39013532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards an improved understanding of drug excipient interactions to enable rapid optimization of nanosuspension formulations.
    Ferrar JA; Sellers BD; Chan C; Leung DH
    Int J Pharm; 2020 Mar; 578():119094. PubMed ID: 32006625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of aggregate formation and carbohydrate excipient stabilization of lyophilized humanized monoclonal antibody formulations.
    Andya JD; Hsu CC; Shire SJ
    AAPS PharmSci; 2003; 5(2):E10. PubMed ID: 12866937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Chemical Space for New Substances to Stabilize a Therapeutic Monoclonal Antibody.
    Tosstorff A; Menzen T; Winter G
    J Pharm Sci; 2020 Jan; 109(1):301-307. PubMed ID: 31697947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brij-58, a potential injectable protein-stabilizer used in therapeutic protein formulation.
    Yue L; Yan Z; Li H; Liu X; Sun P
    Eur J Pharm Biopharm; 2020 Jan; 146():73-83. PubMed ID: 31811896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Pharmacokinetic Study on Caffeine as an Excipient for Monoclonal Antibody Formulations.
    Zeng Y; Naik S; Tran T; Wuthrich P; Muni N; Mahoney RP
    J Pharm Sci; 2023 Nov; 112(11):2933-2937. PubMed ID: 37517525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of polyol excipient stability during storage and use on the quality of biopharmaceutical formulations.
    Sun MF; Liao JN; Jing ZY; Gao H; Shen BB; Xu YF; Fang WJ
    J Pharm Anal; 2022 Oct; 12(5):774-782. PubMed ID: 36320601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystalline Antibody-Laden Alginate Particles: A Platform for Enabling High Concentration Subcutaneous Delivery of Antibodies.
    Erfani A; Schieferstein JM; Reichert P; Narasimhan CN; Pastuskovas C; Parab V; Simmons D; Yang X; Shanker A; Hammond P; Doyle PS
    Adv Healthc Mater; 2023 Jun; 12(15):e2202370. PubMed ID: 36745878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-protein interactions and water activity coefficients can be used to aid a first excipient choice in protein formulations.
    Schleinitz M; Sadowski G; Brandenbusch C
    Int J Pharm; 2019 Oct; 569():118608. PubMed ID: 31415881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant Impact on Interfacial Protein Aggregation and Utilization of Surface Tension to Predict Surfactant Requirements for Biological Formulations.
    Vargo KB; Stahl P; Hwang B; Hwang E; Giordano D; Randolph P; Celentano C; Hepler R; Amin K
    Mol Pharm; 2021 Jan; 18(1):148-157. PubMed ID: 33253579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.